academic.oup.com/toxsci/article-pdf/86/2/427/4655989/kfi184.pdf

TBARs were not increased until 14 days (2-fold vs. control, p <. 0.05). Liver toxicity ... lymphocyte toxicity exhibited by VPA (Tabatabaei et al.,. 1999). ... They were fed with rat diet (Labdiet 5001 rodent diet, PMI Feeds Inc., Richmond, IN) and.

journals.plos.org/plosone/article?id=10.1371/journal.pone.0116534

Dec 31, 2014 ... Menegola et al. indicates that VPA exerts its teratogenic effect by .... onto a Protean IEF cell (Bio-Rad Laboratories Inc.) (California, USA) and ... After focusing, the voltage was set at 500 V to avoid further diffusion of the proteins already focused. ..... Tabatabaei AR, Thies RL, Abbott FS (1999) Assessing the ...

cancerres.aacrjournals.org/content/66/13/6563

Jul 1, 2006 ... Valproic acid (VPA) is a widely used anticonvulsive agent that has profound antiproliferative ..... ( 43), or as core sequence by Nguyen et al.

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.586.4036&rep=rep1&type=pdf

v. Acknowledgements. First and foremost, I would like to thank my supervisor, Dr. ..... serendipitously discovered the anticonvulsant activity of VPA (Meunier et al., 1962) and ..... reactive metabolites (Tabatabaei et al., 1999), alterations in glutathione ..... incorporated, Corning, NY), maintained in α-minimum essential medium ...

www.researchgate.net/publication/5650698_Oral_valproic_acid_for_epilepsy-Long-term_experience_in_therapy_and_side_effects

Aug 18, 2018 ... Valproic acid (VPA) is considered to be a drug of first choice and one of the ..... su rvival, ion homeostasis, cytoskeletal modifications and signal.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4281235

Dec 31, 2014 ... Menegola et al. indicates that VPA exerts its teratogenic effect by .... a Protean IEF cell (Bio-Rad Laboratories Inc.) (California, USA) and electrophoresis was conducted at 20°C. The subsequent protocols involved rehydration at 50 V for 12 h and ..... Tabatabaei AR, Thies RL, Abbott FS (1999) Assessing the ...

www.supremecourt.ohio.gov/rod/docs/pdf/9/2009/2009-ohio-3139.pdf

Jun 29, 2009 ... {¶1} Margarita Tabatabai petitioned the Medina County Court of Common Pleas,. Domestic ... Harkai v. Scherba Industries, Inc. (2000), 136 Ohio App.3d 211, ... to all the forms of relief that a court is authorized to grant under.

pdfs.semanticscholar.org/7518/bf4d64d8aca984630b01f3f687c85e0b0660.pdf

Apr 10, 2017 ... evaluate whether VPA is a substrate for MRPs or the efflux transporter ... at the blood-CSF and blood-brain barriers (Sun et al., 2003;. Löscher and ..... tariquidar (XR9576) by Xenova Ltd. (Slough, Berkshire, UK). ()- ...... Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, and Löscher W (2006).

pdfs.semanticscholar.org/246c/5dc278651c9bfdc9a71306c6ffe676d5467a.pdf

V. S. GOPAUL,1 W. TANG,2 K. FARRELL, AND F. S. ABBOTT. Faculties of ... serum concentrations of the three amino acid conjugates of VPA in six patients ... et al., 1988; Abbott and Anari, 1999; Radatz and Nau, 1999). More- .... purchased from BDH Chemicals (Toronto, ON) or Caledon Laboratories Ltd. (Edmonton, AB) .